Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;95(1):113-123.
doi: 10.1016/j.mayocp.2019.05.036. Epub 2019 Dec 4.

Serum Bicarbonate Concentration and Cause-Specific Mortality: The National Health and Nutrition Examination Survey 1999-2010

Sadeer G Al-Kindi  1 , Anuja Sarode  2 , Melissa Zullo  2 , Sanjay Rajagopalan  3 , Mahboob Rahman  4 , Thomas Hostetter  4 , Mirela Dobre  4
Affiliations

Serum Bicarbonate Concentration and Cause-Specific Mortality: The National Health and Nutrition Examination Survey 1999-2010

Sadeer G Al-Kindi et al. Mayo Clin Proc. 2020 Jan.

Abstract

Objective: To assess the association between serum bicarbonate concentration and cause-specific mortality in the US general population.

Methods: A total of 31,195 individuals enrolled in the National Health and Nutrition Examination Survey between 1999 and 2010 were followed for a median 6.7 (interquartile range, 3.7-9.8) years. Cause-specific mortality was defined as cardiovascular, malignancy, and noncardiovascular/nonmalignancy causes. Cox proportional hazards adjusted for demographics, comorbidities, medications, and renal function were used to test the association between baseline serum bicarbonate and the outcomes of interest.

Results: Of the 2798 participants who died, 722 had a cardiovascular- and 620 had a malignancy-related death. Compared with participants with serum bicarbonate 22 to 26 mEq/L, those with a level below 22 mEq/L had an increased hazard of all-cause and malignancy-related mortality (hazard ratio [HR], 1.54; 95% CI, 1.30-1.83; and HR, 1.46; 95% CI 1.00-2.13, respectively). The hazard for cardiovascular mortality was increased by 8% with each 1 mEq/L increase in serum bicarbonate above 26 mEq/L (HR, 1.08; 95% CI, 1.01-1.15). The findings were consistent in participants with or without chronic kidney disease, with no significant interactions observed.

Conclusion: In a large cohort of US adults, serum bicarbonate concentration level below 22 mEq/L was associated with malignancy-related mortality, whereas a concentration above 26 mEq/L was associated with cardiovascular mortality. Further studies to evaluate potential mechanisms for the differences in cause-specific mortality are warranted.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest: The authors report no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
Consort diagram.
FIGURE 2.
FIGURE 2.. Demographic adjusted curves for cause-specific mortality by baseline serum bicarbonate strata (< 22 mEq/L, 22 – 26 mEq/L and > 26 mEq/L). (A) All-cause mortality (B) Cardiovascular mortality (C) Cancer mortality.
Analysis was done using Kaplan-Meier method accounting for complex survey design. P-values are of Log-Rank (Mantel-Cox) test.
FIGURE 3.
FIGURE 3.
Adjusted (model 3) penalized smoothing splines for all-cause, cardiovascular- and cancer-mortality (unweighted data). Gray lines represent 95% confidence interval. Red line represents HR of 1.
FIGURE 4.
FIGURE 4.. Bicarbonate levels and cause-specific mortality in subgroups
CKD=chronic kidney disease, DM=Diabetes Mellitus. P values are for interaction between subgroup and bicarbonate levels. Analysis was done using Cox regression accounting for complex survey design
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis. 2005;45(6): 978–993. - PubMed
    1. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009;24(4): 1232–1237. - PMC - PubMed
    1. Dobre M, Yang W, Chen J, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2013;62(4):670–678. - PMC - PubMed
    1. Dobre M, Yang W, Pan Q, et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): a report from the Chronic Renal Insufficiency Cohort (CRIC) study. J Am Heart Assoc. 2015; 4(4):e001599. - PMC - PubMed
    1. Navaneethan SD, Schold JD, Arrigain S, et al. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(10):2395–2402. - PMC - PubMed